| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 5 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | United States | 5 | |
| #4 | Brazil | 4 | |
| #5 | United Kingdom | 4 | |
| #6 | Mexico | 4 | |
| #7 | WIPO (World Intellectual Property Organization) | 4 | |
| #8 | Australia | 2 | |
| #9 | South Africa | 2 | |
| #10 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Maze Mervyn | 30 |
| #2 | Franks Nicholas Peter | 25 |
| #3 | Franks Nicholas P | 2 |
| #4 | Peter Franks Nicholas | 1 |
| #5 | Franks N P | 1 |
| #6 | Mervyn Maze | 1 |
| #7 | Maze M | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP1670489A1 | Use of xenon with hypothermia for treating neonatal asphyxia | |
| GB0418540D0 | Use | |
| GB0418539D0 | Use | |
| GB0323861D0 | Use | |
| GB0209998D0 | Use | |
| US6653354B2 | NMDA antagonist comprising xenon |